Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineering Bioinspired Nanomedicines to Mitigate the Resistance to Cancer Immunotherapy
Jiayi Ye, Bo Hou, Madiha Saeed, et al.
Accounts of Materials Research (2022) Vol. 3, Iss. 7, pp. 697-708
Closed Access | Times Cited: 21

Showing 21 citing articles:

Biomineralized MnO2 Nanoplatforms Mediated Delivery of Immune Checkpoint Inhibitors with STING Pathway Activation to Potentiate Cancer Radio-Immunotherapy
Zheng Deng, Min Xi, Cai Zhang, et al.
ACS Nano (2023) Vol. 17, Iss. 5, pp. 4495-4506
Closed Access | Times Cited: 87
Single-Site Nanozymes with a Highly Conjugated Coordination Structure for Antitumor Immunotherapy via Cuproptosis and Cascade-Enhanced T Lymphocyte Activity
Yang Liu, Rui Niu, Huan Zhao, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 6, pp. 3675-3688
Closed Access | Times Cited: 56
A STING pathway-activatable contrast agent for MRI-guided tumor immunoferroptosis synergistic therapy
Shuai Guo, Wei Xiong, Jiaoyang Zhu, et al.
Biomaterials (2023) Vol. 302, pp. 122300-122300
Closed Access | Times Cited: 47
Exploring nanocarriers as innovative materials for advanced drug delivery strategies in onco-immunotherapies
Pratiksha Tiwari, Ravi Prakash Shukla, Krishna Yadav, et al.
Journal of Molecular Graphics and Modelling (2024) Vol. 128, pp. 108702-108702
Closed Access | Times Cited: 19
Nanovesicles loaded with a TGF-β receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapy
Mengxue Zhou, Jiaxin Wang, Jiaxing Pan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 39
Beyond Drug Delivery System: Immunomodulatory Layered Double Hydroxide Nanoadjuvants Take an Essential Step Forward in Cancer Immunotherapy
Chaojie Zhu, Jianping Jiang, Yingbo Jia, et al.
Accounts of Materials Research (2023) Vol. 4, Iss. 9, pp. 758-771
Closed Access | Times Cited: 28
STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross-presentation for cancer immunotherapy
Nguyen Thi Nguyen, Xuan Thien Le, Woo Tak Lee, et al.
Bioactive Materials (2024) Vol. 42, pp. 345-365
Open Access | Times Cited: 8
In-situ vaccination immunotherapy of colorectal cancer with STING agonist-integrated supramolecular nanovectors
Xiaoying Liu, Fangmin Chen, Madiha Saeed, et al.
Nano Today (2024) Vol. 56, pp. 102273-102273
Closed Access | Times Cited: 7
Self‐Adaptive Nanoregulator to Mitigate Dynamic Immune Evasion of Pancreatic Cancer
Jiaxing Pan, Yi Lai, Shunan Zhang, et al.
Advanced Materials (2023) Vol. 35, Iss. 47
Closed Access | Times Cited: 12
Stimuli‐Responsive Nano Drug Delivery Systems for the Treatment of Neurological Diseases
Xi‐jian Dai, Weilong Li, Dongdong Xie, et al.
Small (2025) Vol. 21, Iss. 9
Closed Access
Topology regulation of nanomedicine for autophagy-augmented ferroptosis and cancer immunotherapy
Ruizhi Hu, Chen Dai, Xinyue Dai, et al.
Science Bulletin (2022) Vol. 68, Iss. 1, pp. 77-94
Open Access | Times Cited: 15
The advancement of metalloadjuvant for cancer immunotherapy
Fangmin Chen, Haijun Yu
Science Bulletin (2023) Vol. 68, Iss. 8, pp. 756-758
Open Access | Times Cited: 7
Self‐Immolated Nanoadjuvant for In Situ Vaccination Immunotherapy of Colorectal Cancer
Weiqi Wang, Qiwen Zhu, Yilan Jin, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 23
Closed Access | Times Cited: 7
Tumor-specific delivery of clickable inhibitor for PD-L1 degradation and mitigating resistance of radioimmunotherapy
Bo Hou, Jiayi Ye, Lujia Huang, et al.
Science Advances (2024) Vol. 10, Iss. 46
Open Access | Times Cited: 2
In-situ clickable prodrug nanoplatform locally activates T lymphocytes to potentiate cancer immunotherapy
Bo Hou, Jiayi Ye, Junhao Li, et al.
Nano Today (2022) Vol. 47, pp. 101661-101661
Closed Access | Times Cited: 11
Cell delivery devices for cancer immunotherapy
Ping Wen, Wei Wu, Feifan Wang, et al.
Journal of Controlled Release (2022) Vol. 353, pp. 875-888
Closed Access | Times Cited: 11
Self‐Cooperative Prodrug Nanovesicles Migrate Immune Evasion to Potentiate Chemoradiotherapy in Head and Neck Cancer
Yun Zhu, Shunan Zhang, Yi Lai, et al.
Advanced Science (2022) Vol. 9, Iss. 36
Open Access | Times Cited: 9
Dynamic polyphenol nanoparticles boost cuproptosis-driven metalloimmunotherapy of breast cancer
Huijuan Zhang, Fangmin Chen, Wen‐Hao Cheng, et al.
Nano Today (2024) Vol. 58, pp. 102442-102442
Closed Access | Times Cited: 1
Nanotechnology as an emerging option in cancer immunotherapy
Manar Abdelhalem, Yousr Mahmoud Ibrahim, Habiba Mohamed Ibrahim, et al.
Elsevier eBooks (2024), pp. 37-70
Closed Access
Engineered Platelet for In Situ Natural Killer Cell Activation to Inhibit Tumor Recurrence
Yueyang Deng, Caixia Tan, Shuguang Huang, et al.
Nano Letters (2024) Vol. 24, Iss. 38, pp. 11814-11822
Closed Access
Heteroantigen-assembled nanovaccine enhances the polyfunctionality of TILs against tumor growth and metastasis
Liangnian Wei, Ye Zhang, Ruixin Wang, et al.
Biomaterials (2023) Vol. 302, pp. 122297-122297
Closed Access | Times Cited: 1
Page 1

Scroll to top